181 related articles for article (PubMed ID: 36746678)
1. Synthesis and discovery of potential tyrosinase inhibitor of new coumarin-based thiophenyl-pyrazolylthiazole nuclei: In vitro evaluation, cytotoxicity, kinetic, and computational studies.
Hosseini Nasab N; Raza H; Eom YS; Hassan M; Kloczkowski A; Kim SJ
Chem Biol Drug Des; 2023 Jun; 101(6):1262-1272. PubMed ID: 36746678
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
[TBL] [Abstract][Full Text] [Related]
3. Thiazol-4(5H)-one analogs as potent tyrosinase inhibitors: Synthesis, tyrosinase inhibition, antimelanogenic effect, antioxidant activity, and in silico docking simulation.
Jung Park Y; Jin Jung H; Jin Kim H; Soo Park H; Lee J; Yoon D; Kyung Kang M; Young Kim G; Ullah S; Kang D; Park Y; Chun P; Young Chung H; Ryong Moon H
Bioorg Med Chem; 2024 Jan; 98():117578. PubMed ID: 38154348
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
[TBL] [Abstract][Full Text] [Related]
5. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
[TBL] [Abstract][Full Text] [Related]
7. Identification and molecular mechanism of novel 5-alkenyl-2-benzylaminothiazol-4(5H)-one analogs as anti-melanogenic and antioxidant agents.
Kang MK; Yoon D; Jung HJ; Ullah S; Lee J; Park HS; Kim HJ; Kang D; Park Y; Chun P; Young Chung H; Moon HR
Bioorg Chem; 2023 Nov; 140():106763. PubMed ID: 37566943
[TBL] [Abstract][Full Text] [Related]
8. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
9. (
Jung HJ; Noh SG; Ryu IY; Park C; Lee JY; Chun P; Moon HR; Chung HY
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233397
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of tyrosinase inhibiting novel bi-heterocyclic acetamides: Mechanistic insights through enzyme inhibition, kinetics and computational studies.
Butt ARS; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Raza H; Hassan M; Shah SAA; Shahid M; Seo SY
Bioorg Chem; 2019 May; 86():459-472. PubMed ID: 30772647
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors.
Mahdavi M; Ashtari A; Khoshneviszadeh M; Ranjbar S; Dehghani A; Akbarzadeh T; Larijani B; Khoshneviszadeh M; Saeedi M
Chem Biodivers; 2018 Jul; 15(7):e1800120. PubMed ID: 29766648
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, in Vitro, and in Silico Evaluation of N-Phenylacetamide-Oxindole-Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors.
Yari Boroujeni S; Haghighijoo Z; Mohammadi-Khanaposhtani M; Mosadeghkhah A; Moazzam A; Yavari A; Hajimahmoodi M; Sabourian R; Hosseini S; Larijani B; Hamedifar H; Ansari S; Mahdavi M
Chem Biodivers; 2022 Apr; 19(4):e202100666. PubMed ID: 35156774
[TBL] [Abstract][Full Text] [Related]
14. Coumarin-Based Compounds as Inhibitors of Tyrosinase/Tyrosine Hydroxylase: Synthesis, Kinetic Studies, and In Silico Approaches.
Nunes JA; Araújo RSA; Silva FND; Cytarska J; Łączkowski KZ; Cardoso SH; Mendonça-Júnior FJB; Silva-Júnior EFD
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982292
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (
Bang E; Noh SG; Ha S; Jung HJ; Kim DH; Lee AK; Hyun MK; Kang D; Lee S; Park C; Moon HR; Chung HY
Molecules; 2018 Dec; 23(12):. PubMed ID: 30551624
[TBL] [Abstract][Full Text] [Related]
16. Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.
Ashraf Z; Rafiq M; Nadeem H; Hassan M; Afzal S; Waseem M; Afzal K; Latip J
PLoS One; 2017; 12(5):e0178069. PubMed ID: 28542395
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Bi-heterocyclic Sulfonamides as Tyrosinase Inhibitors: Lineweaver-Burk Plot Evaluation and Computational Ascriptions.
Abbasi MA; Rehman ZU; Rehman AU; Siddiqui SZ; Nazir M; Hassan M; Raza H; Shah SAA; Seo SY
Acta Chim Slov; 2020 Jun; 67(2):403-414. PubMed ID: 33855544
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis of Cinnamyl-paeonol derivatives with 1, 3-Dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro.
Tang K; Jiang Y; Zhang H; Huang W; Xie Y; Deng C; Xu H; Song X; Xu H
Bioorg Chem; 2021 Jan; 106():104512. PubMed ID: 33293056
[TBL] [Abstract][Full Text] [Related]
20. Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors.
Ferro S; De Luca L; Germanò MP; Buemi MR; Ielo L; Certo G; Kanteev M; Fishman A; Rapisarda A; Gitto R
Eur J Med Chem; 2017 Jan; 125():992-1001. PubMed ID: 27810600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
